ICAR Technologies:High-Value Nutraceutical andNutritional Products from Seaweeds
2020
The rich diversity of seaweeds in the Indian marine biosphere represents an
untapped reservoir of bioactive compounds with valuable pharmaceutical and
biomedical use. Over the last few years, the use of seaweeds for the development
of new products and as a source for obtaining high-value compounds has attracted
much interest from both food and pharmaceutical industries. The research team
at ICAR-Central Marine Fisheries Research Institute (CMFRI), Kochi developed a
hitherto unraveled database of seaweeds with small molecular weight bioactive
molecules to combat various life-threatening diseases. This subsequently paved the
way for the development of several nutraceutical products for use against arthritis,
type-2 diabetes, dyslipidemia, hypothyroidism, osteoporosis, low immunity, and
hypertension. The latest efforts in this line of research have yielded a seaweedbased
probiotic nutraceutical and an anti-bacterial ointment. ICAR-Central Institute
of Fisheries Technology (CIFT), Kochi with its expertise in post-harvest processing
and value addition has developed several seaweed-based products with antiinflammatory,
anti-diabetic, anti-cancer and immune-modulating properties.
Their product range also includes several seaweed-based ready-to-eat products,
which are gaining popularity. Lately, the COVID-19 pandemic has prompted the
researchers to develop a sanitizer with seaweed as a constituent.
Development of value-added products from underutilized seaweed species also
has the potential to expand the opportunities for their downstream value chain
augmentation, thereby boosting the livelihoods of resource-poor fisherfolk and
budding entrepreneurs across the coastal belt. Coupled with a renewed policy
Preface
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI